"paper"

Underdetection of COVID-19 cases in France threatens epidemic control

Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Happy New Year 2021 from the EAN, the Home of Neurology

Mononeuritis multiplex: an unexpectedly frequent feature of severe COVID-19

Neurological Predictors of Clinical Outcomes in Hospitalized Patients With COVID-19

Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot region

The Impact of SARS-CoV-2 on Stroke Epidemiology and Care: A Meta-analysis

Comprehensive health assessment three months after recovery from acute COVID-19

Neurological manifestations associated with COVID-19: a multicentric registry

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

COVID-19 and Cerebrovascular Diseases: A Systematic Review and Perspectives for Stroke Management

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with COVID-19

Societal Impact of Pain (SIP) is an international multi-stakeholder platform. Its long-term priorities are pain indicators, pain education, pain in employment, and pain research. This year traditional SIP Stakeholder Forum was on October 28th, 2020.

December's Executive Page is written by Elena Moro